JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Cooperation between an activated oncogene like RASV12 and mutations in cell polarity genes like scribbled, result in tumor growth in Drosophila where tumor cells also display invasive behaviors. Here a simple protocol for the induction and observation of the benign and invasive tumors is presented.

Streszczenie

Drosophila has illuminated our understanding of the genetic basis of normal development and disease for the past several decades and today it continues to contribute immensely to our understanding of complex diseases 1-7. Progression of tumors from a benign to a metastatic state is a complex event 8 and has been modeled in Drosophila to help us better understand the genetic basis of this disease 9. Here I present a simple protocol to genetically induce, observe and then analyze the progression of tumors in Drosophila larvae. The tumor induction technique is based on the MARCM system 10 and exploits the cooperation between an activated oncogene, RasV12 and loss of cell polarity genes (scribbled, discs large and lethal giant larvae) to generate invasive tumors 9. I demonstrate how these tumors can be visualized in the intact larvae and then how these can be dissected out for further analysis. The simplified protocol presented here should make it possible for this technique to be utilized by investigators interested in understanding the role of a gene in tumor invasion.

Wprowadzenie

Progression of tumors from a benign to a metastatic state is a step wise process that is characterized by evasion of protective mechanisms present in the body 8. For example tumor cells in the body must be able to evade apoptosis and the immune system, breakthrough the specialized extracellular matrix (ECM) called Basement Membrane, and overcome any social controls imposed by the surrounding cells 8. It is through a step wise progression that the cancer cells acquire the ability to migrate and colonize distant sites in a process called metastasis. Our understanding of how the tumor cell overcomes the barriers imposed by the body is still in its infancy, however, the emerging picture from research done thus far points to a repeated use of normal developmental processes and signaling pathways by the cancer cells 11-13.

The fruit fly Drosophila melanogaster has contributed tremendously to our understanding of normal development and disease through use of sophisticated genetic techniques developed over the past several decades 14-17. Using mutagenesis and overexpression tools we have arrived at a better understanding of various oncogenes and tumor suppressor genes 18-22. However, tumor metastasis is a result of cooperation between several genetic lesions that has been studied primarily in cell culture models 23,24 as well as various xenograft models 25-27. These models though powerful have their limitations as they do not mimic entirely the conditions found in a living organism. Furthermore, transgenic models available in mice are cumbersome and not conducive to genetic analysis of invasive behavior 28,29. Several studies have attempted to understand invasion of tumor cells in Drosophila 30,31. These techniques primarily utilize transplantation of primary tumors to hosts and then rely on tracking the transplanted tumors for invasion of neighboring tissues 32,33. A powerful technique called MARCM 10 was adapted by Pagliarini and Xu to model tumor invasion in Drosophila 9. This elegant genetic modeling of tumor invasion exploited the cooperation between an activated oncogene and the loss of cell polarity. The power of this modeling lies in the fact that the invasive tumors are created in an intact organism thus circumventing the need for transplantation of tissues. To bring about the oncogenic cooperation, an activated oncogene like RasV12 is expressed in clones of cells in the larval eye-antennal disc. As a result of the MARCM technique these clones are also marked with green fluorescent protein (GFP) for easy visualization and are made homozygous for cell polarity mutants like lethal giant larvae, scribbled, and discs large. The result is GFP tagged invasive tumors in the cephalic complex. In this report I demonstrate how to induce, and visualize these invasive tumors both in the context of an intact larvae and in dissected out cephalic complex. The tumor induction presented here utilizes reagents on the second chromosome of Drosophila. In Table 2, I provide a listing of stocks on X and 3rd chromosomes that can be utilized for the same purpose. I believe that this simplified protocol will make this technique readily accessible to researchers interested in understanding the molecular basis of tumor progression.

Access restricted. Please log in or start a trial to view this content.

Protokół

1. Induction of Benign Non-invasive Tumors

  1. Use stocks listed in Table 2 for the induction of benign tumors.
  2. Prepare a starter culture for the "tester" stock of the following genotype: y,w, ey-FLP1; Tub-Gal80,FRT40A; Act5C>y+>Gal4, UAS-GFP
  3. Prepare a starter culture for the "tested" stock of the following genotype: w; FRT40A, UAS-RasV12/CyO
  4. Collect ten female virgins from the "tester" stock and ten males from the "tested" stock.
  5. Cross the males and females from the "tester" and the "tested" stock by placing them both in a vial with fly food.
  6. Place the cross in a 25 °C incubator and allow the males and females to mate and lay eggs for 24-48 hr.
  7. Check the vials for sufficient egg deposition and for the presence of first instar larvae making sure that the culture is not drying out.
    1. Add a few drops of autoclaved distilled water to the culture to keep it moist (if the culture is drying out).
    2. Continue to monitor the culture and repeat step 1.7.1 as needed.
  8. Observe wandering third instar larvae under a fluorescence stereomicroscope as outlined in section 3.

2. Induction of Invasive Tumors

  1. Use stocks listed in Table 2 for the induction of invasive tumors.
  2. Use the starter culture from step 1.2 above of the following genotype: y,w, ey-FLP1; Tub-Gal80,FRT40A; Act5C>y+>Gal4, UAS-GFP
  3. Prepare a starter culture for the "tested" stock of the following genotype: w; lgl4, FRT40A, UAS-RasV12/CyO
  4. Collect ten female virgins from the "tester" stock and ten males from the "tested" stock.
  5. Cross the males and females from the "tester" and the "tested" stock by placing them both in a vial with fly food.
  6. Place the cross in a 25 °C incubator and allow the males and females to mate and lay eggs for 24-48 hr.
  7. Check the vials for sufficient egg deposition and for the presence of first instar larvae making sure that the culture is not drying out.
    1. Add a few drops of autoclaved distilled water to the culture to keep it moist (if the culture is drying out).
    2. Continue to monitor the culture for dryness and repeat step 2.7.1 as needed.
  8. Observe third instar larvae under a fluorescence stereomicroscope as outlined in section 3.

3. Observation of Benign and Invasive Tumors

  1. Use third instar larvae for benign tumor isolation and visualization.
    1. Wet a paint brush in distilled water, and using this paint brush scrape a few third instar larvae from the wall of the culture vial.
    2. Place larvae in a depression slide with 1X PBS and then using a wet paint brush scrape off any food material from the larval epidermis.
    3. Place the larvae in a Petri plate and leave at -20 °C freezer for 30 min to immobilize the larva.
      1. Alternative method to immobilize larvae using FLYNAP.
      2. Place a FLYNAP wand dipped in FLYNAP to the vial from 3.1.3.2 and after plugging the vial let plugged vial with larvae stand for 30 to 40 min.
    4. Place the immobilized larva on a glass slide, add a drop of light halocarbon oil, cover with a cover glass and observe under a fluorescence stereomicroscope with the capability to visualize Green Fluorescent Protein (GFP).
    5. The benign tumor bearing larvae will fluoresce green in the anterior region where the cephalic complex is present.
  2. Select day 10 larvae (after induction) from the culture set in step #2 above for observation of invasive tumors. Day 10 larvae are selected because invasive tumor bearing larvae have an extended larval stage and generally fail to pupariate.
  3. Follow steps 3.1.1 to 3.1.4 except instead of third instar larvae use day 10 larvae.
    1. The day 10 invasive tumor bearing larvae will fluoresce green in the anterior region where the cephalic complex is present.
  4. If the fluorescent microscope is equipped with a digital camera then take pictures of the fluorescing benign and invasive tumor bearing larvae.

4. Dissection of the Cephalic Complex and Further Observation of Benign and Invasive Tumors

The translucent epidermis of the larva makes it difficult to observe the extent of invasion of tumors. Thus the extent of invasion is better visualized by dissecting the cephalic complex out of the larva. The following steps should be utilized to dissect the cephalic complex.

  1. Using a wet paint brush select third instar larvae (for benign tumors) and day 10 larvae (for invasive tumors) from the respective culture vials.
  2. Place larvae in a well of a dissection dish containing cold 1X PBS. Use paint brush to scrape off any food particles from the larval epidermis.
    1. Transfer clean larvae to a fresh well of the dissection dish containing cold 1X PBS.
    2. Check for presence of GFP fluorescence using a stereomicroscope capable of detecting fluorescence. Discard non-GFP bearing larvae.
  3. Add 1.0ml of cold 1X PBS to a fresh well on the dissection dish and using a pair of forceps transfer a larva bearing either the benign or invasive tumors (the dissection protocol remains the same for these two types of tumors).
  4. Hold the larva down using a pair of forceps about 2/3rds from the anterior end.
    1. Use the other pair of forceps and smartly separate the posterior 1/3rd of the larva and discard it.
    2. Let go of the anterior 2/3rds of the larva. As the pressure inside the larva is released the contents of the larva will ooze out of the body cavity.
    3. Use a pair of forceps to remove the gut, fat body and other inner contents of the larva that have oozed out of the body cavity.
    4. Use a pair of forceps to hold the mouth hook of the larva and push it into the larval epidermis and using the other pair of forceps invert the larva completely.
    5. Use the forceps to gently and carefully remove the fat body, salivary glands, gut, the wing disc complex and any tracheal tubes. The cephalic complex should now be visible attached to the mouth hook of the inverted larva. The brain hemispheres and the ventral nerve cord (VNC) would still be connected to the larval epidermis through the nerves emanating from the VNC.
    6. Use a pair of forceps to gently break the connections between the cephalic nerves and the larval epidermis.
    7. As the nerve connections between the VNC and the larval epidermis are broken and excess fat body and other tissue removed, the cephalic complex would become clearly visible and will be attached to the larval epidermis only at the mouth hooks.
    8. The cephalic complex can be left attached to the larval epidermis if the complex needs to be fixed for downstream applications like antibody staining or for later visualization.
    9. If no further downstream applications would be performed then the cephalic complex can be detached from the larval epidermis and placed in a drop of a glycerol based mounting media for further observation and analysis. Use VECTASHIELD as the mounting media.

Access restricted. Please log in or start a trial to view this content.

Wyniki

As a result of the protocol presented here the user will be able to induce benign tumors by overexpressing an activated oncogene in the larval eye antennal imaginal disc. The user will also be able to induce invasive tumors in the eye antennal disc by overexpressing an activated oncogene in clones of cells also mutant for a cell polarity gene. The tumors could be easily visualized with the help of a fluorescent stereomicroscope as "green fluorescent" tissue in the whole larvae or in cephalic complexes that have been diss...

Access restricted. Please log in or start a trial to view this content.

Dyskusje

Cancer is a complex disease with a much better understanding today than in the past. However, much still needs to be learnt and explained before we have a complete picture of the underlying mechanisms. The simple protocol presented here makes it possible to genetically induce benign and invasive tumors in a whole organism and then study the biology associated with the progression of tumors in this model. Most of the existing techniques in Drosophila and other organisms either utilize a cell culture based system ...

Access restricted. Please log in or start a trial to view this content.

Ujawnienia

I have nothing to disclose.

Podziękowania

Research in my laboratory is supported by the WKU Department of Biology startup funds, WKU Research Foundation RCAP-I grant # 11-8032 and by a KBRIN-AREA grant funded through a parent grant from the National Institute of General Medical Sciences of the National Institutes of Health under award number 5P20GM103436-13. I would also like to acknowledge Dr. Tian Xu in whose laboratory I was introduced to this technique and Dr. Raymond Pagliarini who first established this technique in the Xu laboratory.

Access restricted. Please log in or start a trial to view this content.

Materiały

NameCompanyCatalog NumberComments
10X PBS (phosphate buffered saline) pH 7.2 stock solutionInvitrogen, Sigma Aldrich
Chilled 1X PBS pH7.2 working solutionInvitrogen, Sigma AldrichMake fresh and refrigerate, can be used up to a week
FlynapCarolina BiologicalsFly anesthesia needed to anesthetize larvae
Fixative0.1M PIPES, pH 7.2, 4% ParaformaldehydeNeeded to fix the dissected cephalic complex
Ice BucketSeveralMaintain solutions on ice. Also, dissect cephalic complex in chilled 1X PBS and then place on ice in an Eppendorf tube
1.7ml Eppendorf tubeVarious
Glass slides, cover glassFisher Scientific
Vectashield Mounting Media or any other mounting mediaVector Laboratories
Halocarbon 200 or 700 OilPolysciences Inc. or Halocarbon.comHalocarbon 200 is used to mount the larvae for visualization on a fluorescence stereoscope
Sally Hansen "Hard as Nails" nail polishCan be found at any general merchandise storeNeeded to seal the edges of Coverslip
A Leica MZ16.5 fluorescence stereomicroscope or any other fluorescence stereomicroscopeLeica and othersNeeded to observe the GFP fluorescence in larvae
Dumont #5 forcepsFine Science Tools
Pyrex 9 well spot plate or any other dissection dishSigma Aldrich
Paint BrushCan be found at any general merchandise store
Table 1. Materials needed to perform the experimental protocol presented in this article.

Odniesienia

  1. Bale, A. E. Hedgehog signaling and human disease. Annu Rev Genomics Hum Genet. 3, 47-65 (2002).
  2. Bier, E., Bodmer, R. Drosophila, an emerging model for cardiac disease. Gene. 342, 1-11 (2004).
  3. Coombs, G. S., Covey, T. M., Virshup, D. M. Wnt signaling in development, disease and translational medicine. Curr Drug Targets. 9, 513-531 (2008).
  4. Gistelinck, M., Lambert, J. C., Callaerts, P., Dermaut, B., Dourlen, P. Drosophila models of tauopathies: what have we learned. Int J Alzheimers Dis. 2012, 970980(2012).
  5. Marsh, J. L., Thompson, L. M. Drosophila in the study of neurodegenerative disease. Neuron. 52, 169-178 (2006).
  6. Reiter, L. T., Bier, E. Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins. Expert Opin Ther Targets. 6, 387-399 (2002).
  7. Valenta, T., Hausmann, G., Basler, K. The many faces and functions of beta-catenin. EMBO J. 31, 2714-2736 (2012).
  8. Hanahan, D., Weinberg, R. A. Hallmarks of cancer: the next generation. Cell. 144, 646-674 (2011).
  9. Pagliarini, R. A., Xu, T. A genetic screen in Drosophila for metastatic behavior. Science. 302, 1227-1231 (2003).
  10. Wu, J. S., Luo, L. A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat Protoc. 1, 2583-2589 (2006).
  11. Boccaccio, C., Comoglio, P. M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer. 6, 637-645 (2006).
  12. Srivastava, A., Pastor-Pareja, J. C., Igaki, T., Pagliarini, R., Xu, T. Basement membrane remodeling is essential for Drosophila disc eversion and tumor invasion. Proc Natl Acad Sci U S A. 104, 2721-2726 (2007).
  13. Wang, W., Eddy, R., Condeelis, J. The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer. 7, 429-440 (2007).
  14. Brand, A. GFP as a cell and developmental marker in the Drosophila nervous system. Methods Cell Biol. 58, 165-181 (1999).
  15. Brand, A. H., Dormand, E. L. The GAL4 system as a tool for unravelling the mysteries of the Drosophila nervous system. Curr Opin Neurobiol. 5, 572-578 (1995).
  16. Vidal, M., Cagan, R. L. Drosophila models for cancer research. Curr Opin Genet Dev. 16, 10-16 (2006).
  17. Parks, A. L., et al. Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome. Nat Genet. 36, 288-292 (2004).
  18. Blair, S. S. Genetic mosaic techniques for studying Drosophila development. Development. 130, 5065-5072 (2003).
  19. Xu, T., Rubin, G. M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development. 117, 1223-1237 (1993).
  20. Xu, T., Wang, W., Zhang, S., Stewart, R. A., Yu, W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development. 121, 1053-1063 (1995).
  21. Rebay, I., et al. A genetic screen for novel components of the Ras/Mitogen-activated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif-containing protein. Genetics. 154, 695-712 (2000).
  22. Therrien, M., Morrison, D. K., Wong, A. M., Rubin, G. M. A genetic screen for modifiers of a kinase suppressor of Ras-dependent rough eye phenotype in Drosophila. Genetics. 156, 1231-1242 (2000).
  23. Albini, A., et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245 (1987).
  24. Zicha, D., Dunn, G. A., Brown, A. F. A new direct-viewing chemotaxis chamber. J Cell Sci. 99 (Pt 4), 769-775 (1991).
  25. Fidler, I. J. New developments in in vivo models of neoplasia. Cancer Metastasis Rev. 10, 191-192 (1991).
  26. Mueller, B. M., Romerdahl, C. A., Trent, J. M., Reisfeld, R. A. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res. 51, 2193-2198 (1991).
  27. Konantz, M., et al. Zebrafish xenografts as a tool for in vivo studies on human cancer. Ann N Y Acad Sci. 1266, 124-137 (2012).
  28. McIntyre, R. E., vander Weyden, L., Adams, D. J. Cancer gene discovery in the mouse. Curr Opin Genet Dev. 22, 14-20 (2012).
  29. Mattison, J., vander Weyden, L., Hubbard, T., Adams, D. J. Cancer gene discovery in mouse and man. Biochim Biophys Acta. 1796, 140-161 (2009).
  30. Miles, W. O., Dyson, N. J., Walker, J. A. Modeling tumor invasion and metastasis in Drosophila. Dis Model Mech. 4, 753-761 (2011).
  31. Stefanatos, R. K., Vidal, M. Tumor invasion and metastasis in Drosophila: a bold past, a bright future. J Genet Genomics. 38, 431-438 (2011).
  32. Beaucher, M., et al. Drosophila brain tumor metastases express both neuronal and glial cell type markers. Dev Biol. 301, 287-297 (2007).
  33. Beaucher, M., Hersperger, E., Page-McCaw, A., Shearn, A. Metastatic ability of Drosophila tumors depends on MMP activity. Dev Biol. 303, 625-634 (2007).
  34. Joyce, J. A., Pollard, J. W. Microenvironmental regulation of metastasis. Nat Rev Cancer. 9, 239-252 (2009).
  35. Igaki, T., Pagliarini, R. A., Xu, T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol. 16, 1139-1146 (2006).
  36. Uhlirova, M., Jasper, H., Bohmann, D. Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model. Proc Natl Acad Sci U S A. 102, 13123-13128 (2005).
  37. Uhlirova, M., Bohmann, D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J. 25, 5294-5304 (2006).
  38. Menut, L., et al. A mosaic genetic screen for Drosophila neoplastic tumor suppressor genes based on defective pupation. Genetics. 177, 1667-1677 (2007).
  39. Wu, M., Pastor-Pareja, J. C., Xu, T. Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature. 463, 545-548 (2010).

Access restricted. Please log in or start a trial to view this content.

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Keywords Drosophila MelanogasterGenetic InductionBenign TumorsInvasive TumorsCephalic ComplexesMARCM SystemRasV12Cell Polarity GenesTumor ProgressionTumor VisualizationTumor DissectionGenetic Basis Of Disease

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone